Category Archives: AZBio News
TGen study identifies gene fusion as likely cause of rare type of thyroid cancer
Genomic sequencing of 62-year-old patient leads to new treatment optionContinue reading
SynCardia Total Artificial Heart Could Become the Life-Saving Answer to Heart Transplant Graft Failure
SynCardia Systems, Inc. Continues to Make Progress for Approval of the SynCardia Heart for Permanent Use to Save Patients Who Are Unlikely to Receive Another Donor HeartContinue reading
TGen-led study spotlights dog DNA role in developing new therapies for human cancers
Study shows timeframe for canine sample analysis fits clinical window for human medical advancementsContinue reading
Mayo Clinic Cancer Center elected to prestigious NCCN.
Mayo Clinic Cancer Center and Yale Cancer Center/Smilow Cancer Hospital Named Newest NCCN Member InstitutionsContinue reading
DxInsights to Host Diagnostics Summit
Forward-thinking Summit to be Held at the University of Arizona / Miraval InstituteContinue reading
What Our Community Can Do Together: AZBio’s CEO Looks Back and Forward
On March 21, 2011, I was granted the opportunity by AZBio’s Board of Directors to become our association’s president and ceo. What’s happened since then is a testament to what can happen when we come together as a community. —- Joan Koerber-WalkerContinue reading
Pinnacle Transplant Technologies Claims “Venture Madness” Crown
From a field of 64 early-stage companies emerged a single champion, Pinnacle Transplant Technologies, a multi-service tissue bank and client company of the Center for Entrepreneurial Innovation (CEI) at GateWay Community College.Continue reading
Tallwave expands competition to include Health IT
UA Researchers Awarded Collaborative Flinn Foundation Grant to Unravel Lung Virome
Research team to study role of CMV persistence in the lung and its effect on the pulmonary virome, as well as translate findings to treatments.Continue reading